AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36037232 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized interventions using the Well‐Beat system
Number of subjects: 95
Study 36037232 — intervention group
Group type: COMPARATOR
Intervention: Historical control group
Number of subjects: 95
Study 32081036 — intervention group
Group type: EXPERIMENTAL
Intervention: Circadian insulin infusion rates
Number of subjects: 17
Study 32081036 — intervention group
Group type: COMPARATOR
Intervention: Flat insulin infusion rates
Number of subjects: 17
Study 32771068 — intervention group
Group type: EXPERIMENTAL
Intervention: Online self-help leaflet intervention
Number of subjects: 60
Study 32771068 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 60
Study 34320937 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light treatment (BLT) using ceiling mounted LED-panels providing light at 1000 lx and 6000 K between 10 a.m. and 3 p.m.
Number of subjects: 69
Study 34320937 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light treatment (BLT)
Number of subjects: 69
Study 34320937 — intervention group
Group type: COMPARATOR
Intervention: Standard indoor light (control group)
Number of subjects: 69
Study 35093596 — intervention group
Group type: EXPERIMENTAL
Intervention: CSEA+AI
Number of subjects: 360
Study 35093596 — intervention group
Group type: COMPARATOR
Intervention: CSEA
Number of subjects: 360
Study 35093596 — intervention group
Group type: COMPARATOR
Intervention: AI
Number of subjects: 360
Study 35093596 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 360
Study 33858696 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress taper fixation
Number of subjects: 14
Study 33858696 — intervention group
Group type: COMPARATOR
Intervention: Bicortical fixation
Number of subjects: 14
Study 35045396 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention (n = 23), 45 minutes for 12 weeks
Number of subjects: 43
Study 35045396 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 20)
Number of subjects: 43
Study 32114877 — intervention group
Group type: EXPERIMENTAL
Intervention: Otago Exercise Program (OEP)
Number of subjects: 175
Study 32114877 — intervention group
Group type: EXPERIMENTAL
Intervention: Otago Exercise Program with Motivational Interviewing (OEP with MI)
Number of subjects: 175
Study 32114877 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 175
Study 36001070 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan
Number of subjects: 40
Study 36001070 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 32321763 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet patterns in cases of dementia (n = 209)
Number of subjects: 627
Study 32321763 — intervention group
Group type: COMPARATOR
Intervention: Diet patterns in controls (n = 418)
Number of subjects: 627
Study 35397754 — intervention group
Group type: EXPERIMENTAL
Intervention: INVEST intervention (cognitive-behavioural therapy informed vestibular rehabilitation)
Number of subjects: 40
Study 35397754 — intervention group
Group type: COMPARATOR
Intervention: Gold standard vestibular rehabilitation (VRT)
Number of subjects: 40
Study 34167464 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of doctor-patient communication skills
Number of subjects: 400
Study 34167464 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice of doctor-patient communication skills
Number of subjects: 400
Study 34167464 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictors of better practice scores
Number of subjects: 400
Study 35428690 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 0
Study 35428690 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 0
Study 35428690 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomograms for overall survival
Number of subjects: 0
Study 35428690 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomograms for cancer specific death
Number of subjects: 0
Study 32418846 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha Lipoic Acid (ALA) 1200 mg daily
Number of subjects: 53
Study 32418846 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 35842566 — intervention group
Group type: EXPERIMENTAL
Intervention: EOX plus aspirin (150 mg daily)
Number of subjects: 95
Study 35842566 — intervention group
Group type: COMPARATOR
Intervention: EOX alone
Number of subjects: 95
Study 34291796 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple Antibiotic Solution (TAS)
Number of subjects: 88
Study 34291796 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine Gluconate (CHG)
Number of subjects: 88
Study 35550060 — intervention group
Group type: EXPERIMENTAL
Intervention: Elotuzumab plus lenalidomide and dexamethasone
Number of subjects: 748
Study 35550060 — intervention group
Group type: COMPARATOR
Intervention: Lenalidomide and dexamethasone
Number of subjects: 748
Study 32027206 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual Art Therapy (VAT)
Number of subjects: 39
Study 32027206 — intervention group
Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 39
Study 32754150 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient powder (MNP) with 5 mg iron daily for 4 months starting at age 7.5 months
Number of subjects: 573
Study 32754150 — intervention group
Group type: COMPARATOR
Intervention: Micronutrient powder (MNP) without iron
Number of subjects: 573
Study 32754150 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoglobin at time of vaccination
Number of subjects: 573
Study 32754150 — intervention group
Group type: EXPERIMENTAL
Intervention: Anemia and serum transferrin receptor at time of vaccination
Number of subjects: 573
Study 36448359 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitality acupunch (VA) exercise program for 6 months
Number of subjects: 103
Study 35272776 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicuspid aortic stenosis
Number of subjects: 145
Study 35272776 — intervention group
Group type: COMPARATOR
Intervention: Tricuspid aortic stenosis
Number of subjects: 145
Study 32756930 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal Manipulation
Number of subjects: 162
Study 32756930 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal Mobilization
Number of subjects: 162
Study 32756930 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Sham Cold Laser Therapy)
Number of subjects: 162
Study 35526782 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniocentesis
Number of subjects: 397
Study 34273907 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapists' perceptions based on client vignettes with varying class and race descriptions
Number of subjects: 138
Study 34273907 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapists' confidence in diagnosis
Number of subjects: 138
Study 34273907 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic recommendations based on client vignettes
Number of subjects: 138
Study 32854842 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Field Ablation (PFA) for pulmonary vein isolation (PVI) and left atrial posterior wall (LAPW) ablation
Number of subjects: 25
Study 34111810 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm combining ICD codes and FVIII/FIX activity <0.4 IU/ml
Number of subjects: 2642
Study 32093701 — intervention group
Group type: EXPERIMENTAL
Intervention: PUSH notifications from a mobile app for improving body composition
Number of subjects: 0
Study 32093701 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 36001055 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG-rhG-CSF
Number of subjects: 100
Study 36001055 — intervention group
Group type: COMPARATOR
Intervention: rhG-CSF
Number of subjects: 100
Study 34021709 — intervention group
Group type: EXPERIMENTAL
Intervention: F/TAF
Number of subjects: 5387
Study 34021709 — intervention group
Group type: COMPARATOR
Intervention: F/TDF
Number of subjects: 5387
Study 34021709 — intervention group
Group type: COMPARATOR
Intervention: Counterfactual bHIV
Number of subjects: 5387
Study 33376301 — intervention group
Group type: EXPERIMENTAL
Intervention: Brexpiprazole
Number of subjects: 0
Study 33448930 — intervention group
Group type: EXPERIMENTAL
Intervention: On-demand SRH mHealth platform (ARMADILLO)
Number of subjects: 30
Study 33448930 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed enhancements to the platform
Number of subjects: 30
Study 36084228 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT) - supervised progressive total body heavy RT program 2 times per week for 12 weeks
Number of subjects: 20
Study 36084228 — intervention group
Group type: COMPARATOR
Intervention: Control group - instructed to continue their everyday life
Number of subjects: 20
Study 33047411 — intervention group
Group type: EXPERIMENTAL
Intervention: MAS063DP
Number of subjects: 16
Study 33047411 — intervention group
Group type: COMPARATOR
Intervention: white petrolatum
Number of subjects: 16
Study 35421283 — intervention group
Group type: EXPERIMENTAL
Intervention: CHAIR
Number of subjects: 18
Study 35421283 — intervention group
Group type: COMPARATOR
Intervention: LAB
Number of subjects: 18
Study 33591139 — intervention group
Group type: EXPERIMENTAL
Intervention: Superficial cervical plexus block (CPB)
Number of subjects: 70
Study 33591139 — intervention group
Group type: COMPARATOR
Intervention: Combined superficial cervical plexus block and interscalene block (ISB)
Number of subjects: 70
Study 32936790 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium and Sugammadex (Group RS)
Number of subjects: 102
Study 32936790 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium and Neostigmine (Group RN)
Number of subjects: 102
Study 32936790 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium and Neostigmine (Group CN)
Number of subjects: 102
Study 35351037 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT), one session per week for 3 to 4 months
Number of subjects: 60
Study 34447583 — intervention group
Group type: EXPERIMENTAL
Intervention: Surfactant + Budesonide
Number of subjects: 128
Study 34447583 — intervention group
Group type: COMPARATOR
Intervention: Surfactant
Number of subjects: 128
Study 35763229 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoendocrine therapy (CET)
Number of subjects: 13500
Study 35763229 — intervention group
Group type: COMPARATOR
Intervention: Endocrine therapy (ET)
Number of subjects: 13500
Study 35763229 — intervention group
Group type: EXPERIMENTAL
Intervention: CET
Number of subjects: 13500
Study 33356994 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion at 100% of basal rate
Number of subjects: 26
Study 33356994 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion at 150% of basal rate
Number of subjects: 26
Study 33356994 — intervention group
Group type: COMPARATOR
Intervention: Intense exercise compared to moderate exercise
Number of subjects: 26
Study 33356994 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion rate effect on AUCRd
Number of subjects: 26
Study 34893041 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive method (n=74)
Number of subjects: 439
Study 34893041 — intervention group
Group type: EXPERIMENTAL
Intervention: Group discussion by dentists (n=59)
Number of subjects: 439
Study 34893041 — intervention group
Group type: EXPERIMENTAL
Intervention: Face to face education by primary health care providers (n=53)
Number of subjects: 439
Study 34893041 — intervention group
Group type: EXPERIMENTAL
Intervention: Social network (n=53)
Number of subjects: 439
Study 34893041 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=200)
Number of subjects: 439
Study 36351459 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin plus a high-dose infusion for 2-4 hours after PCI
Number of subjects: 6016
Study 36351459 — intervention group
Group type: COMPARATOR
Intervention: Heparin monotherapy
Number of subjects: 6016
Study 33524981 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral bipolar plasmakinetic enucleation of the prostate (PKEP)
Number of subjects: 0
Study 33524981 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 0
Study 32294317 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic clinical SYNTAX score
Number of subjects: 205
Study 32294317 — intervention group
Group type: COMPARATOR
Intervention: Anatomical CABG SYNTAX score
Number of subjects: 205
Study 35083337 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training in municipality setting (1 hour, twice weekly for 12 weeks)
Number of subjects: 72
Study 35083337 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training in hospital setting (1 hour, twice weekly for 12 weeks)
Number of subjects: 72
Study 35083337 — intervention group
Group type: COMPARATOR
Intervention: General population (reference data)
Number of subjects: 72
Study 33313759 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic inflammatory regulators
Number of subjects: 455258
Study 33313759 — intervention group
Group type: COMPARATOR
Intervention: Alzheimer's disease
Number of subjects: 455258
Study 32250714 — intervention group
Group type: COMPARATOR
Intervention: brodalumab 210 mg every 2 weeks (Q2W)
Number of subjects: 0
Study 32250714 — intervention group
Group type: COMPARATOR
Intervention: brodalumab 210 mg Q2W
Number of subjects: 0
Study 32250714 — intervention group
Group type: EXPERIMENTAL
Intervention: ustekinumab
Number of subjects: 0
Study 34379363 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in a randomized trial between two types of radiation
Number of subjects: 1046
Study 34379363 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in a randomized trial between two treatment durations
Number of subjects: 1046
Study 35834861 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperglycemia on admission (serum glucose >7.8 mmol/L)
Number of subjects: 173
Study 35834861 — intervention group
Group type: COMPARATOR
Intervention: Normoglycemic patients (serum glucose ≤7.8 mmol/L)
Number of subjects: 173
Study 34530433 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-minute interset rest interval (ISRI)
Number of subjects: 10
Study 34530433 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-minute interset rest interval (ISRI)
Number of subjects: 10
Study 34530433 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-minute ISRI
Number of subjects: 10
Study 34530433 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-minute ISRI
Number of subjects: 10
Study 33310665 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozonated autohemotherapy
Number of subjects: 18
Study 33310665 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 18
Study 34172825 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination pill
Number of subjects: 620
Study 34172825 — intervention group
Group type: COMPARATOR
Intervention: No contraception
Number of subjects: 620
Study 32703001 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror book therapy in conjunction with standard facial rehabilitation
Number of subjects: 25
Study 32703001 — intervention group
Group type: COMPARATOR
Intervention: Facial physical rehabilitation without mirror book therapy
Number of subjects: 25
Study 33269808 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Prolonged Exposure Therapy (mPE)
Number of subjects: 74
Study 33269808 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care Treatment (SoC)
Number of subjects: 74
Study 32000725 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) with VR exposure based on 360° videos
Number of subjects: 90
Study 32000725 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) with in vivo exposure
Number of subjects: 90
Study 32000725 — intervention group
Group type: COMPARATOR
Intervention: VR relaxation therapy
Number of subjects: 90
Study 35412227 — intervention group
Group type: EXPERIMENTAL
Intervention: Treat-and-extend (T&E) regimen
Number of subjects: 458
Study 35412227 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro re nata (PRN) regimen
Number of subjects: 458
Study 35412227 — intervention group
Group type: COMPARATOR
Intervention: Fixed dosing regimen
Number of subjects: 458
Study 34770193 — intervention group
Group type: EXPERIMENTAL
Intervention: OHEMA (Oral Health Education Mobile App)
Number of subjects: 40
Study 34770193 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 32681134 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory BCI
Number of subjects: 20
Study 32681134 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile BCI
Number of subjects: 20
Study 32681134 — intervention group
Group type: COMPARATOR
Intervention: Auditory BCI to Tactile BCI switch
Number of subjects: 20
Study 32681134 — intervention group
Group type: COMPARATOR
Intervention: Tactile BCI to Auditory BCI switch
Number of subjects: 20
Study 37142054 — intervention group
Group type: COMPARATOR
Intervention: Endometrial scratch (not explicitly mentioned as an intervention in this study)
Number of subjects: 40
Study 33704352 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.COV2.S vaccine (5×10^10 or 1×10^11 viral particles)
Number of subjects: 25
Study 33704352 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 32058543 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening mammography
Number of subjects: 0
Study 32058543 — intervention group
Group type: COMPARATOR
Intervention: All-cause mortality
Number of subjects: 0
Study 33587827 — intervention group
Group type: EXPERIMENTAL
Intervention: Youth and family engagement in research and service design
Number of subjects: 28
Study 33587827 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitators of engagement
Number of subjects: 28
Study 33587827 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers to engagement
Number of subjects: 28
Study 33587827 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall impact of engagement
Number of subjects: 28
Study 32648810 — intervention group
Group type: EXPERIMENTAL
Intervention: brexpiprazole 2–4 mg/day
Number of subjects: 1405
Study 32648810 — intervention group
Group type: EXPERIMENTAL
Intervention: brexpiprazole 1–4 mg/day
Number of subjects: 1405
Study 32648810 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1405
Study 34735776 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially supervised physical activity intervention (3 hours of vigorous PA per week)
Number of subjects: 117
Study 34735776 — intervention group
Group type: COMPARATOR
Intervention: Control group (no change in PA behavior)
Number of subjects: 117
Study 33713718 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment (MWD + CDO)
Number of subjects: 120
Study 33713718 — intervention group
Group type: COMPARATOR
Intervention: MWD
Number of subjects: 120
Study 33713718 — intervention group
Group type: COMPARATOR
Intervention: CDO
Number of subjects: 120
Study 33046070 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure (SBP)
Number of subjects: 5852
Study 33046070 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure (SBP) in patients with additional cardiovascular disease (CVD)
Number of subjects: 5852
Study 33046070 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure (SBP) in patients with only the index ACS
Number of subjects: 5852
Study 35151572 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised Exercise Therapy (SET)
Number of subjects: 240
Study 35151572 — intervention group
Group type: COMPARATOR
Intervention: Endovascular Revascularisation (ER)
Number of subjects: 240
Study 35151572 — intervention group
Group type: EXPERIMENTAL
Intervention: SET
Number of subjects: 240
Study 35151572 — intervention group
Group type: COMPARATOR
Intervention: ER
Number of subjects: 240
Study 33899268 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prophylaxis with oral hygiene instructions only (test)
Number of subjects: 62
Study 33899268 — intervention group
Group type: COMPARATOR
Intervention: Subgingival instrumentation (control)
Number of subjects: 62
Study 33899268 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (test and control)
Number of subjects: 62
Study 34911035 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Deprivation Training (SDT)
Number of subjects: 1
Study 35673945 — intervention group
Group type: EXPERIMENTAL
Intervention: Scapular stabilization exercises and postural correction exercises
Number of subjects: 60
Study 35673945 — intervention group
Group type: COMPARATOR
Intervention: Postural correctional exercises
Number of subjects: 60
Study 35184491 — intervention group
Group type: EXPERIMENTAL
Intervention: Four doses of 20 µg vaccination
Number of subjects: 273
Study 35184491 — intervention group
Group type: EXPERIMENTAL
Intervention: Four doses of 60 µg vaccination
Number of subjects: 273
Study 35184491 — intervention group
Group type: COMPARATOR
Intervention: Three doses of 20 µg vaccination
Number of subjects: 273
Study 35184491 — intervention group
Group type: EXPERIMENTAL
Intervention: CKD patients without immune suppression or hormone therapy
Number of subjects: 273
Study 34782599 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery plus extensive intraoperative peritoneal lavage (EIPL)
Number of subjects: 662
Study 34782599 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 662
Study 34625003 — intervention group
Group type: EXPERIMENTAL
Intervention: Battlefield acupuncture (BFA)
Number of subjects: 69
Study 34625003 — intervention group
Group type: COMPARATOR
Intervention: Routine standard care only (Control)
Number of subjects: 69
Study 32039879 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS over the contralesional primary motor cortex and iTBS over the ipsilesional M1 (Group A)
Number of subjects: 28
Study 32039879 — intervention group
Group type: COMPARATOR
Intervention: Contralesional 1 Hz rTMS and ipsilesional sham iTBS (Group B)
Number of subjects: 28
Study 32039879 — intervention group
Group type: COMPARATOR
Intervention: Contralesional sham 1 Hz rTMS and ipsilesional sham iTBS (Group C)
Number of subjects: 28
Study 35149266 — intervention group
Group type: EXPERIMENTAL
Intervention: autologous mesenchymal stem cells (aMSCs) therapy (n = 9)
Number of subjects: 20
Study 35149266 — intervention group
Group type: COMPARATOR
Intervention: placebo infusion (n = 11)
Number of subjects: 20
Study 32189096 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention (BI)
Number of subjects: 48
Study 32189096 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 48